These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 8104394

  • 1. Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment.
    Burris JF.
    Arch Intern Med; 1993 Sep 27; 153(18):2085-92. PubMed ID: 8104394
    [Abstract] [Full Text] [Related]

  • 2. Effects of antihypertensive drugs on lipid metabolism.
    Leren P.
    Clin Ther; 1987 Sep 27; 9(3):326-32. PubMed ID: 2886221
    [Abstract] [Full Text] [Related]

  • 3. [Antihypertensive therapy and modification of metabolic risk factors (glucose and lipid metabolism)].
    Klein W.
    Z Kardiol; 1992 Jun 27; 81(6):295-302. PubMed ID: 1353932
    [Abstract] [Full Text] [Related]

  • 4. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S, Bakir SE.
    Drugs; 2000 Jun 27; 59 Spec No 2():25-37. PubMed ID: 11002856
    [Abstract] [Full Text] [Related]

  • 5. Beta-blockers, plasma lipids, and coronary heart disease.
    Cruickshank JM.
    Circulation; 1990 Sep 27; 82(3 Suppl):II60-5. PubMed ID: 1975524
    [Abstract] [Full Text] [Related]

  • 6. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ, Muhlestein JB, Bair TL, Renlund DG, Lappé DL, Jensen KR, Horne BD, Carter MA, Anderson JL, Intermountain Heart Collaborative Study Group.
    Am J Cardiol; 2005 Apr 01; 95(7):827-31. PubMed ID: 15781009
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Beta-blockers in hypertension.
    Hansson L.
    J Hypertens Suppl; 1987 Aug 01; 5(3):S61-7. PubMed ID: 2889813
    [Abstract] [Full Text] [Related]

  • 13. Beta-blockade in the primary prevention of coronary heart disease in hypertensive patients. Review of present evidence.
    Wikstrand J, Berglund G, Tuomilehto J.
    Circulation; 1991 Dec 01; 84(6 Suppl):VI93-100. PubMed ID: 1683615
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety of antihypertensive therapy.
    Grossman E, Messerli FH.
    Prog Cardiovasc Dis; 2006 Dec 01; 49(1):16-25. PubMed ID: 16867847
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
    Kountz DS.
    Postgrad Med; 2009 Jan 01; 121(1):14-24. PubMed ID: 19179810
    [Abstract] [Full Text] [Related]

  • 17. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F, Ragot S, Julien J, Herpin D.
    Arch Mal Coeur Vaiss; 2005 Sep 01; 98(9):881-8. PubMed ID: 16231574
    [Abstract] [Full Text] [Related]

  • 18. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B, Brilla C, Kruse T, Noll B, Bethge C.
    Herz; 1995 Dec 01; 20(6):370-89. PubMed ID: 8582697
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Beta-blockers in hypertension.
    Ram CV.
    Am J Cardiol; 2010 Dec 15; 106(12):1819-25. PubMed ID: 21126627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.